Sort
4,870 grants matching “glp 1”
An ultra-long-acting oral treatment for opioid use disorder
$278,504Andrew Martin Bellinger · Lyndra Therapeutics, Inc. · UG3 · FY2019 · DA
Mucus Penetrating Nanoparticles for Small Cell Lung Cancer
$278,437Justin S. Hanes · Johns Hopkins University · U54 · FY2012 · CA
IMPARIED AMINO-ACID SENSING/SIGNALING IN BONE MARROW OSTEOPROGENITOR CELLS
$278,387Carlos Miguel Isales · Augusta University · P01 · FY2014 · AG
Role of GLP-1 in Congenital Hyperinsulinism
$278,207Diva Del Carmen De Leon · Children'S Hosp Of Philadelphia · R56 · FY2009 · DK
HISTONE VARIANTS IN RODENT DEPRESSION MODELS
$278,161Charles David Allis · Icahn School Of Medicine At Mount Sinai · P50 · FY2013 · MH
First-in-class TREM-1 inhibitors for neovascular retinal diseases
$278,127Alexander B Sigalov · Signablok, Inc. · R44 · FY2023 · EY
Core C: Product Analysis Core
$277,997Maciej Lukasz Goniewicz · Roswell Park Cancer Institute Corp · U54 · FY2022 · CA
Development of a qualified pharmacokinetic bioassay to support preclinical and clinical studies of MM-008, a non-hormonal contraceptive antibody
$277,713Keiichiro Kushiro · Mucommune, Llc · R43 · FY2022 · HD
"Subunit Vaccines for Brucella Pathogens"
$277,196David W Pascual · University Of Florida · R01 · FY2012 · AI
Glial Progenitor Cells for Treatment of ALS
$276,845Linda L Kelley · University Of Utah · U01 · FY2010 · NS
Chronic exposure to Biphenol A and uterine cancer risk markers
$276,702Shuk-Mei Ho · University Of Cincinnati · U01 · FY2013 · ES
MOLECULAR ANALYSIS OF GLP-1 RECEPTOR ACTIVATION
$276,500Tufts Medical Center · R01 · FY2001 · DK
MOLECULAR ANALYSIS OF GLP-1 RECEPTOR ACTIVATION
$276,500Tufts Medical Center · R01 · FY2002 · DK
MOLECULAR ANALYSIS OF GLP-1 RECEPTOR ACTIVATION
$276,500Tufts Medical Center · R01 · FY2000 · DK
MOLECULAR ANALYSIS OF GLP-1 RECEPTOR ACTIVATION
$276,500Tufts Medical Center · R01 · FY2003 · DK
A Phase I/IIa Clinical Trial Testing the Safety and Immunogenicity of a Heroin Vaccine and its Efficacy Against Morphine Challenge.
$276,354Gary R. Matyas · Henry M. Jackson Fdn For The Adv Mil/Med · UG3 · FY2019 · DA
CEST MRI Agents for Receptor Imaging
$276,237Michael T McMahon · Johns Hopkins University · P41 · FY2017 · EB
Central Viscerosensory Circuits-Structure and Function
$275,859Linda M Rinaman · University Of Pittsburgh At Pittsburgh · R01 · FY2007 · MH
Product Development and Manufacturing Core
$275,822Becky L Rivoire Phd · Colorado State University · U54 · FY2009 · AI
Translational development of novel CRISPR approach to treat genomic duplications
$275,651Monkol Lek · Myofinity Biosciences Inc · R41 · FY2023 · AR
Ligand-Directed KRAS G12V Mutant-Specific Therapeutics
$275,645Lyla Stanland · Enfuego Therapeutics Inc. · R44 · FY2023 · CA
Central Viscerosensory Circuits-Structure and Function
$275,581Linda M Rinaman · University Of Pittsburgh At Pittsburgh · R01 · FY2008 · MH
Metabolic Effects of Melanocortin 4 Receptor Agonism
$275,485Ranganath Muniyappa · National Institute Of Diabetes And Digestive And Kidney Diseases · ZIA · FY2017 · DK
Biobehavioral Studies of Obesity, Weight loss and Recidivism
$275,485Ranganath Muniyappa · National Institute Of Diabetes And Digestive And Kidney Diseases · ZIA · FY2017 · DK
Dissecting mechanisms of GLP-1 based therapies for Type II Diabetes
$275,202Randy J. Seeley · University Of Michigan At Ann Arbor · R01 · FY2014 · DK